Training an LLM at a frontier lab? Get bulk hospital pricing data.
Contact sales@medprice.ai →
☀️
medprice.ai
Examples
Connect
Hospitals
Payers
Codes
Request data
Get access
☀️
medprice.ai
Examples
Connect
Hospitals
Payers
Codes
Request data
Get access
HCPCS codes — hospital pricing directory | medprice.ai
☀️
medprice.ai
Examples
Connect
Hospitals
Payers
Codes
Request data
Get access
Home
/
Codes
/
HCPCS
HCPCS codes
31221 HCPCS codes with hospital pricing data in the network.
Hospital prices
Payer rates
i
Chooses where each code opens, and where the search below sends you: to the hospitals’ prices for the code, or to what each payer pays for it.
Most samples
Most hospitals
Fewest samples
Fewest hospitals
Highest price
Lowest price
Widest spread
Code ↑
Code ↓
Descriptions:
AI description
Original text
AI-written plain-English titles; the original text is what hospitals report.
Code or procedure name
Go
HCPCS G9814
— Death during index hospital stay
AI
(33 hospitals, — samples)
· median $7
HCPCS G9815
— Patient did not die during this hospital stay
AI
(33 hospitals, — samples)
· median $7
HCPCS G9816
— Patient death within 30 days after discharge
AI
(33 hospitals, — samples)
· median $7
HCPCS G9817
— No 30-day death after discharge
AI
(33 hospitals, — samples)
· median $7
HCPCS G9818
— Documentation of sexual activity
AI
(226 hospitals, — samples)
· median $0
HCPCS G9819
—
← Prev
Page 192 of 625
Next →
Quality measure: patient in hospice during reporting period
AI
(218 hospitals, — samples)
· median $0
HCPCS G9820
— Chlamydia screening test with follow-up
AI
(227 hospitals, — samples)
· median $0
HCPCS G9821
— Chlamydia screening: no documentation, with follow-up
AI
(218 hospitals, — samples)
· median $0
HCPCS G9822
— Endometrial ablation procedure year of prior date
AI
(222 hospitals, — samples)
· median $0
HCPCS G9823
— Uterine lining sampling or hysteroscopy biopsy, results documented
AI
(222 hospitals, — samples)
· median $0
HCPCS G9824
— Endometrial sampling or hysteroscopy biopsy, results not documented
AI
(222 hospitals, — samples)
· median $0
HCPCS G9825
— HER2-negative status, documentation unknown
AI
(33 hospitals, — samples)
· median $7
HCPCS G9826
— Transfer practice after initial chemotherapy
AI
(33 hospitals, — samples)
· median $7
HCPCS G9827
— HER2-targeted therapy, not initial treatment
AI
(33 hospitals, — samples)
· median $7
HCPCS G9828
— HER2-targeted therapy during initial treatment
AI
(33 hospitals, — samples)
· median $7
HCPCS G9829
— Adjuvant chemotherapy administration for breast cancer
AI
(33 hospitals, — samples)
· median $7
HCPCS G9830
— HER-2 positive test
AI
(218 hospitals, — samples)
· median $0
HCPCS G9831
— Breast cancer staging, stage II or III
AI
(224 hospitals, — samples)
· median $0
HCPCS G9832
— Breast cancer stage I, excluding T1 tumor categories
AI
(224 hospitals, — samples)
· median $0
HCPCS G9833
— Transfer to practice after initial chemotherapy
AI
(33 hospitals, — samples)
· median $7
HCPCS G9834
— Patient had metastatic disease at diagnosis
AI
(33 hospitals, — samples)
· median $7
HCPCS G9835
— Trastuzumab treatment within 12 months of diagnosis
AI
(33 hospitals, — samples)
· median $7
HCPCS G9836
— Documented reason trastuzumab was not given
AI
(33 hospitals, — samples)
· median $7
HCPCS G9837
— Trastuzumab not given within 12 months, diagnosis
AI
(33 hospitals, — samples)
· median $7
HCPCS G9838
— Patient with metastatic disease at diagnosis
AI
(218 hospitals, — samples)
· median $0
HCPCS G9839
— Monoclonal antibody therapy targeting EGFR
AI
(224 hospitals, — samples)
· median $0
HCPCS G9840
— Genetic testing performed
AI
(222 hospitals, — samples)
· median $0
HCPCS G9841
— Genetic testing not performed
AI
(222 hospitals, — samples)
· median $0
HCPCS G9842
— Metastatic disease present at diagnosis
AI
(218 hospitals, — samples)
· median $0
HCPCS G9843
— KRAS or NRAS gene mutation test
AI
(218 hospitals, — samples)
· median $0
HCPCS G9844
— Patient not receiving anti-EGFR therapy
AI
(218 hospitals, — samples)
· median $0
HCPCS G9845
— Patient received anti-EGFR therapy
AI
(218 hospitals, — samples)
· median $0
HCPCS G9846
— Patient died from cancer
AI
(218 hospitals, — samples)
· median $0
HCPCS G9847
— Chemotherapy received in the final 14 days of life
AI
(218 hospitals, — samples)
· median $0
HCPCS G9848
— Patient did not receive chemotherapy in last 14 days of life
AI
(218 hospitals, — samples)
· median $0
HCPCS G9849
— Patient death from cancer
AI
(33 hospitals, — samples)
· median $7
HCPCS G9850
— Emergency room visits in final 30 days of life
AI
(33 hospitals, — samples)
· median $7
HCPCS G9851
— No emergency department visit in final 30 days of life
AI
(33 hospitals, — samples)
· median $7
HCPCS G9852
— Patient died from cancer (quality reporting measure)
AI
(41 hospitals, — samples)
· median $1
HCPCS G9853
— Intensive care stay in final 30 days of life
AI
(41 hospitals, — samples)
· median $1
HCPCS G9854
— No ICU stay in last 30 days of life
AI
(41 hospitals, — samples)
· median $1
HCPCS G9855
— Patient died from cancer
AI
(33 hospitals, — samples)
· median $7
HCPCS G9856
— Patient not in hospice care
AI
(33 hospitals, — samples)
· median $7
HCPCS G9857
— Hospice patient admission
AI
(33 hospitals, — samples)
· median $7
HCPCS G9858
— Patient enrollment in hospice care
AI
(218 hospitals, — samples)
· median $0
HCPCS G9859
— Patient death from cancer
AI
(218 hospitals, — samples)
· median $0
HCPCS G9860
— Hospice stay of less than 3 days
AI
(218 hospitals, — samples)
· median $0
HCPCS G9861
— Patient in hospice more than three days
AI
(218 hospitals, — samples)
· median $0
HCPCS G9862
— Documented reason for no 10-year follow-up
AI
(222 hospitals, — samples)
· median $0
HCPCS G9892
— Documented reason patient had no dilated macular exam
AI
(106 hospitals, — samples)
· median $1